Immunological characterization of epitopes on tau of Alzheimer's type and chemically modified tau

被引:0
|
作者
Farias, G
GonzalezBillault, C
Maccioni, RB
机构
[1] INT CTR CANC & DEV BIOL ICC,SANTIAGO 7,CHILE
[2] UNIV CHILE,FAC SCI,DEPT BIOL,CELLULAR & MOL BIOL LAB,SANTIAGO 7,CHILE
关键词
tau isoforms; protein carbamoylation; tau glycation; paired-helical filaments; site-directed monoclonal antibodies; Alzheimer's disease;
D O I
10.1023/A:1006838626730
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
The microtubule-associated protein tau is the main structural component of paired helical filaments (PHFs), which in turn are one of the major aberrant polymers found in Alzheimer's disease. Immunological studies were carried out using site-directed monoclonal and polyclonal antibodies that recognize tubulin binding epitopes on tau, to further understand the mechanisms of tau self-association into PHFs. Tau protein was subjected to either carbamoylation with potassium cyanate (KCNO) or glycation with glucose, and the immunoreactivity of the chemically-modified protein with these antibodies was compared with tau derived from paired helical filaments and with normal brain tau. The data on the immunoblot patterns of tau isoforms and the ELISA titration curves revealed significant differences between the modified tau and normal controls. However, the Western blot patterns of immunoreactive tau from the chemically-modified protein and from Alzheimer brains were similar. The data on the differences in the electrophoretic profiles and Western blots of normal brain tau as compared with solubilized paired helical filaments, insoluble tangles and tau proteins of the Alzheimer's type, provide new clues to understand the anomalous interactions of tau in Alzheimer's disease.
引用
收藏
页码:59 / 66
页数:8
相关论文
共 50 条
  • [21] Dendritic Tau in Alzheimer's Disease
    Ittner, Arne
    Ittner, Lars M.
    NEURON, 2018, 99 (01) : 13 - 27
  • [22] TRACING TAU IN THE ALZHEIMER'S BRAIN
    不详
    CHEMICAL & ENGINEERING NEWS, 2014, 92 (24) : 31 - 31
  • [23] Tau, tangles, and Alzheimer's disease
    Binder, LI
    Guillozet-Bongaarts, AL
    Garcia-Sierra, F
    Berry, RW
    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 2005, 1739 (2-3): : 216 - 223
  • [24] Tau Protein in Alzheimer's Disease
    Maccioni, Ricardo B.
    CURRENT ALZHEIMER RESEARCH, 2011, 8 (06) : 607 - 607
  • [25] Tau Ubiquitination in Alzheimer's Disease
    Li, Longfei
    Jiang, Yanli
    Wang, Jian-Zhi
    Liu, Rong
    Wang, Xiaochuan
    FRONTIERS IN NEUROLOGY, 2022, 12
  • [26] Tau, Neurodegeneration and Alzheimer's Disease
    Alonso, Alejandra del Carmen
    CURRENT ALZHEIMER RESEARCH, 2010, 7 (08) : 653 - 655
  • [27] Aluminium, tau and Alzheimer's disease
    Exley, Christopher
    JOURNAL OF ALZHEIMERS DISEASE, 2007, 12 (04) : 313 - 315
  • [28] The complexity of tau in Alzheimer's disease
    Naseri, Nima N.
    Wang, Hong
    Guo, Jennifer
    Sharma, Manu
    Luo, Wenjie
    NEUROSCIENCE LETTERS, 2019, 705 : 183 - 194
  • [29] Tau immunotherapy for Alzheimer's disease
    Pedersen, Jan Torleif
    Sigurdsson, Einar M.
    TRENDS IN MOLECULAR MEDICINE, 2015, 21 (06) : 394 - 402
  • [30] Tau immunotherapies for Alzheimer's disease
    Hoskin, Justin L.
    Sabbagh, Marwan Noel
    Al-Hasan, Yazan
    Decourt, Boris
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2019, 28 (06) : 545 - 554